Form 4: American Healthcare REIT Director Mathieu Streiff Granted Restricted Stock Upon Re-election

American Healthcare REIT, Inc. Director Mathieu B. Streiff was granted 3,042 shares of restricted common stock on June 25, 2025, following his re-election to the board.

Summary

• Mathieu B. Streiff, a Director of American Healthcare REIT, Inc. (AHR), was granted 3,042 shares of restricted common stock.
• The grant occurred on June 25, 2025, coinciding with his re-election to the company's board of directors.
• These restricted shares will vest on June 25, 2026.
• Following this transaction, Mr. Streiff directly beneficially owns 32,377 shares of common stock.
• Additionally, he indirectly beneficially owns 157,402 shares through The Streiff Family Trust UA DTD 03/26/2013.

Sentiment

Score: 6

Explanation: The filing reports a routine director compensation grant, which is a neutral to slightly positive event as it aligns director interests with shareholders, but does not indicate significant new financial performance or strategic shifts.

Positives

• The grant of restricted stock to Director Mathieu B. Streiff aligns his interests with those of shareholders, as the value of his compensation is tied to the company's future stock performance.
• His re-election to the board indicates continued confidence in his role and contributions to the company's governance.

Future Outlook

The 3,042 shares of restricted common stock granted to Director Mathieu B. Streiff are scheduled to vest on June 25, 2026, indicating a future milestone for this compensation.

Industry Context

The grant of restricted stock to a director upon re-election is a common practice in the U.S. corporate landscape, particularly within the REIT sector, serving as a form of equity-based compensation designed to align the interests of board members with long-term shareholder value.

Comparison to Industry Standards

• This type of equity grant, specifically restricted stock upon re-election, is a standard component of director compensation packages across various industries, including healthcare REITs.
• While specific comparable companies or projects are not detailed in this filing, the mechanism of granting restricted stock with a vesting period is widely adopted by publicly traded companies to incentivize long-term commitment and performance from their board members, similar to practices observed at peers within the healthcare real estate investment trust sector.

Corporate Governance

Related Party Transactions

• Mathieu B. Streiff indirectly beneficially owns 157,402 shares through The Streiff Family Trust UA DTD 03/26/2013, which is a related party transaction in terms of beneficial ownership reporting.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director is intended to align the director's interests with those of shareholders, potentially encouraging decisions that enhance long-term stock value.

Next Steps

• Vesting of the 3,042 restricted common shares on June 25, 2026.

Key Dates

Keywords

American Healthcare REIT, AHR, Mathieu B. Streiff, Director Compensation, Restricted Stock Grant, SEC Form 4, Insider Transaction, Corporate Governance, Equity Compensation